
TP53 mutations occurred in 3% of myeloproliferative neoplasms (MPNs) but 10% of myelofibrosis or blast-phase cohorts in a review of 11 cohort studies.
HHS is looking for five to 10 technology innovators to work in the first round of a program seeking to bring some private-sector entrepreneurial spirit to bear on national healthcare challenges.
Read the full story:
Source: ModernHealthcare.com
Private-sector participants—so-called external innovation fellows—in HHS' Innovation Fellows Program will be paired with HHS employees who have already applied for the program to address four projects, three of which have health information technology components.






